Literature DB >> 24358407

Global endometrial ablation in the presence of essure® microinserts.

Diana Aldape1, Scott G Chudnoff1, Mark D Levie1.   

Abstract

Abnormal uterine bleeding (AUB) affects 30% of women at some time during their reproductive years and is one of the most common reasons a woman sees a gynecologist. Many women are turning to endometrial ablation to manage their AUB. This article reviews the data relating to the available endometrial ablation techniques performed with hysteroscopic sterilization, and focuses on data from patients who had Essure® (Conceptus, San Carlos, CA) coils placed prior to performance of endometrial ablation. Reviewed specifically are data regarding safety and efficacy of these two procedures when combined. Data submitted to the US Food and Drug Administration for the three devices currently approved are reviewed, as well as all published case series. Articles included were selected based on a PubMed search for endometrial ablation (also using the brand names of the different techniques currently available), hysteroscopic sterilization, and Essure.

Entities:  

Keywords:  Abnormal uterine bleeding; Endometrial ablation; Hysteroscopic sterilization

Year:  2013        PMID: 24358407      PMCID: PMC3861947     

Source DB:  PubMed          Journal:  Rev Obstet Gynecol        ISSN: 1941-2797


  11 in total

Review 1.  Endometrial ablation: postoperative complications.

Authors:  Howard T Sharp
Journal:  Am J Obstet Gynecol       Date:  2012-04-06       Impact factor: 8.661

2.  The role of Essure sterilization performed simultaneously with endometrial ablation.

Authors:  Anne Claire Donnadieu; Hervé Fernandez
Journal:  Curr Opin Obstet Gynecol       Date:  2008-08       Impact factor: 1.927

3.  A review of clinical data for currently approved hysteroscopic sterilization procedures.

Authors:  Cindy M Basinski
Journal:  Rev Obstet Gynecol       Date:  2010

4.  Essure sterilization associated with endometrial ablation.

Authors:  A C Donnadieu; X Deffieux; A Gervaise; E Faivre; R Frydman; H Fernandez
Journal:  Int J Gynaecol Obstet       Date:  2007-03-26       Impact factor: 3.561

5.  Concomitant Essure tubal sterilization and Thermachoice endometrial ablation: feasibility and safety.

Authors:  Rafael F Valle; Jesus Valdez; Thomas C Wright; Mary Kenney
Journal:  Fertil Steril       Date:  2006-06-08       Impact factor: 7.329

6.  Concomitant NovaSure endometrial ablation and Essure tubal sterilization: a review of 100 cases.

Authors:  Carmen N Mircea; Ciaran Goojha; John A Thiel
Journal:  J Obstet Gynaecol Can       Date:  2011-04

7.  Women presenting to an emergency facility with abnormal uterine bleeding: patient characteristics and prevalence of anemia.

Authors:  Kristen A Matteson; Christina A Raker; Stephanie B Pinto; Dana Marie Scott; Gary N Frishman
Journal:  J Reprod Med       Date:  2012 Jan-Feb       Impact factor: 0.142

8.  Bilateral cornual abscess after endometrial ablation following Essure sterilization.

Authors:  Nicoline E Jansen; Michel P H Vleugels; Kirsten B Kluivers; Mark E Vierhout
Journal:  J Minim Invasive Gynecol       Date:  2007 Jul-Aug       Impact factor: 4.137

9.  Radiofrequency global endometrial ablation followed by hysteroscopic sterilization.

Authors:  Matthew R Hopkins; Douglas J Creedon; Sherif A El-Nashar; Douglas L Brown; Andrew E Good; Abimbola O Famuyide
Journal:  J Minim Invasive Gynecol       Date:  2007 Jul-Aug       Impact factor: 4.137

10.  Microwave endometrial ablation as an alternative to hysterectomy for the emergent control of uterine bleeding in patients who are poor surgical candidates.

Authors:  Shamima Yeasmin; Kentaro Nakayama; Masako Ishibashi; Atsuko Katagiri; Kouji Iida; Naomi Nakayama; Showa Aoki; Yasushi Kanaoka; Kohji Miyazaki
Journal:  Arch Gynecol Obstet       Date:  2008-12-19       Impact factor: 2.344

View more
  2 in total

1.  Water Vapor Endometrial Ablation for Heavy Menstrual Bleeding: 36-Month Follow-Up of a Prospective, Multicenter Pivotal Clinical Trial.

Authors:  Nicholas Leyland; Micah Harris
Journal:  Int J Womens Health       Date:  2021-02-10

2.  CavatermTM plus treatment in high - risk surgical patients.

Authors:  Zinatossadat Bouzari; Ebrahim Alijanpour; Shahla Yazdani; Azita Ghanbarpour; Ali Bijani; Tahereh Ashraf Ganjoei; Hemmat Gholinia
Journal:  Caspian J Intern Med       Date:  2021-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.